BJDX Bluejay Diagnostics, Inc. Common Stock
XNASStock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Fibonacci levels Insider trading
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
- Industry (SIC)
- SURGICAL & MEDICAL INSTRUMENTS & APPARATUS (3841) · industry map
- Exchange
- XNAS
- Market Cap
- $0.0B
- Employees
- 6
- List Date
- 2021-11-10
- CIK
- 0001704287
- Next Earnings
- 2026-11-06
- Headquarters
- Acton, MA
- Homepage
- https://www.bluejaydx.com
Bluejay Diagnostics Inc is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing system for sepsis triage and monitoring of disease progression. Bluejay's first product candidate, an IL-6 Test for sepsis, is designed to provide accurate, reliable results in approximately 20 minutes from sample-to-result to help medical professionals make earlier and quicker triage/treatment decisions.
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
| Month | '21 | '22 | '23 | '24 | '25 | '26 | Avg |
|---|---|---|---|---|---|---|---|
| Jan | -- | -43.40% | 10.01% | -32.73% | -19.65% | 38.27% | -9.50% |
| Feb | -- | -32.90% | 51.28% | -1.37% | 19.22% | -39.35% | -0.62% |
| Mar | -- | 13.01% | -38.00% | -2.10% | 3.32% | -10.24% | -6.80% |
| Apr | -- | 5.41% | -27.26% | -36.45% | -47.24% | -4.23% | -21.95% |
| May | -- | -27.70% | -21.23% | -1.12% | -23.19% | 11.46% | -12.36% |
| Jun | -- | 3.92% | 16.84% | -85.43% | -2.27% | -44.70% | -22.33% |
| Jul | -- | 7.62% | 34.17% | -31.90% | -9.64% | -27.12% | -5.37% |
| Aug | -- | -7.21% | 1.91% | -62.66% | -9.24% | -7.67% | -16.97% |
| Sep | -- | -25.00% | -23.23% | -21.80% | 10.95% | 0.87% | -11.64% |
| Oct | -- | 2.27% | -16.43% | -30.97% | 28.76% | -33.80%* | -10.03% |
| Nov | -46.05% | -17.07% | -6.92% | -16.57% | -26.97% | -- | -22.72% |
| Dec | -3.40% | -43.30% | -62.11% | 37.96% | -46.62% | -- | -23.49% |
| Total | -47.88% | -87.76% | -78.63% | -99.06% | -82.10% | -80.03% | -79.24% |
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
Momentum Oscillators
Volume & Volatility
Data Summary
LLM Stock Analysis Report: BJDX
Executive Summary
Overall Assessment: NEUTRAL with confidence level 6/10
Key Drivers:
- Bullish trend indicators (SMA 20, EMA 12) indicate a potential uptrend
- MACD bearish signal suggests caution
Primary Risks:
- Negative sentiment from recent news headlines
- Low volatility could lead to limited price movement
Investment Thesis: BJDX is in a consolidation phase, with a mix of positive and negative signals. The stock's low volatility and neutral RSI indicate a potential mean reversion, but the bearish MACD signal suggests caution.
Recent News Sentiment Impact: Recent news headlines are mixed, with one positive headline (private placement) and several neutral headlines. This sentiment is not strongly contrarian to technical signals.
Technical Analysis
Trend Direction: Short-term (1-4 weeks): NEUTRAL, Medium-term (1-3 months): BEARISH, Long-term (3-12 months): UPTREND
Support/Resistance Levels:
- Lower Bollinger Band: $0.80
- Middle Band: $1.14
- Upper Band: $1.48
Momentum Signals: RSI interpretation: Neutral (42.31) MACD signal: Bearish (-0.30 / Signal: 0.08 / Histogram: -0.38) Bollinger Bands position: Mean reversion potential, but caution with bearish MACD signal
Volume Analysis: Volume trends indicate a moderate increase in trading activity, suggesting institutional interest.
News & Sentiment Analysis
Recent Headlines Summary: Mixed news sentiment, with one positive headline and several neutral headlines.
Sentiment Assessment: Neutral (average sentiment of recent headlines)
Catalyst Identification: No imminent catalysts identified.
Market Narrative: The market narrative is mixed, with some positive and negative signals. This sentiment is not strongly contrarian to technical signals.
Risk & Volatility Assessment
Beta Interpretation: Low risk relative to market (beta 0.57).
Volatility Regime: Current volatility is low compared to historical levels.
Options Market Signals: No options data available.
Downside Protection: Support levels at $0.80 and $1.14 could provide downside protection.
Market Context & Positioning
Sector Performance: BJDX's sector (Healthcare) has been performing relatively well.
Institutional Activity: Moderate institutional interest signals are present.
Correlation Analysis: The stock's correlation with the market is low (R-squared 0.04), indicating limited dependence on broader market trends.
Relative Valuation: BJDX is trading within a range, with no clear overvaluation or undervaluation signal.
Key Levels & Action Items
Critical Price Levels:
- Support: $0.80 and $1.14
- Resistance: $1.48
Breakout/Breakdown Levels: No immediate levels identified, but the stock's mean reversion potential could be tested if it breaks above or below its current range.
Time-Sensitive Catalysts: None identified.
Risk Management: Consider stop-loss levels at $0.80 and $1.14 for downside protection.
By analyzing the data provided, I have presented a comprehensive analysis of BJDX's technical and fundamental signals. The stock is in a consolidation phase with mixed sentiment from recent news headlines. While there are some bullish trend indicators present, the bearish MACD signal suggests caution. The low volatility and neutral RSI indicate potential mean reversion, but further analysis is required to determine the stock's next move.
BJDX Options Activity & IV Rank
Each spread is ranked by a composite score built in three stages. Full documentation →
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Enter a ticker to render the implied volatility surface.
Enter a ticker to render the implied volatility smile.
Risk Metrics
Analysis Details
Data Points: 251
Period: 252 trading days
Above average volatility - stock moves with market amplification
BJDX Institutional Ownership (13F)
Latest filings — 2026-09-30Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
| # | Filer | Notional Value | % of Total | Period |
|---|
| # | Filer | Notional Value | % of Total | Period |
|---|
BJDX Insider Trading (Form 4)
Latest: 2026-08-18| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-08-18 | Svetlana Dey | Director | Grant (A) | +100,000 opt | — | EDGAR | |
| 2026-08-18 | Fred S Zeidman | Director | Grant (A) | +100,000 opt | — | EDGAR | |
| 2026-08-18 | Indranil Dey | President and CEO | Award (A) | +28,000 | — | EDGAR | |
| 2026-08-18 | Donald R Chase | Director | Grant (A) | +100,000 opt | — | EDGAR | |
| 2026-08-18 | Douglas Clark Wurth | Director | Grant (A) | +100,000 opt | — | EDGAR | |
| 2026-07-13 | HRT FINANCIAL LP | 10%+ Owner | Mixed | +29,109 | $1.47 | $47.8K | EDGAR |
| 2026-05-18 | Fred S Zeidman | Director | Buy (P) | +12,500 | $2.00 | $25.0K | EDGAR |
| 2026-05-18 | Indranil Dey | President and CEO | Buy (P) | +12,500 | $2.00 | $25.0K | EDGAR |
| 2026-05-18 | Svetlana Dey | Director | Buy (P) | +12,500 | $2.00 | $25.0K | EDGAR |
| 2026-05-18 | Douglas Clark Wurth | Director | Buy (P) | +12,500 | $2.00 | $25.0K | EDGAR |
| 2026-05-18 | Donald R Chase | Director | Buy (P) | +12,500 | $2.00 | $25.0K | EDGAR |
| 2023-12-14 | Indranil Dey | President and CEO | Buy (P) | +500 | $3.27 | $1.6K | EDGAR |
| 2023-12-14 | Svetlana Dey | Director | Buy (P) | +500 | $3.07 | $1.5K | EDGAR |
| 2023-03-31 | Indranil Dey | President and CEO | Buy (P) | +10,000 | $0.44 | $4.4K | EDGAR |
| 2023-03-31 | Svetlana Dey | Director | Buy (P) | +10,000 | $0.44 | $4.4K | EDGAR |
BJDX Insider Holdings
6 insiders · @ $0.56| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | HRT FINANCIAL LP | 10%+ Owner | 126,993 | $71.1K | $47.8K | 1 | 2026-07-13 |
| 2 | Indranil Dey | President and CEO | 40,649 | $22.8K | $31.0K | 7 | 2026-08-18 |
| 3 | Svetlana Dey | Director | 12,628 | $7.1K | $42.8K | 9 | 2026-08-18 |
| 4 | Douglas Clark Wurth | Director | 12,608 | $7.1K | $137.5K | 7 | 2026-08-18 |
| 5 | Donald R Chase | Director | 12,525 | $7.0K | $25.0K | 5 | 2026-08-18 |
| 6 | Fred S Zeidman | Director | 12,500 | $7.0K | $25.0K | 5 | 2026-08-18 |
BJDX Board & Officers
As of SEC filings through Aug 18, 2026Directors 5
- Donald R Chase · since Nov 9, 2021
- Douglas Clark Wurth · since Nov 9, 2021
- Fred S Zeidman · since Nov 9, 2021
- Indranil Dey · since Nov 9, 2021
- Svetlana Dey · since Nov 9, 2021
Officers 1
- Indranil Dey · President and CEO · listed since Feb 2022
Changes in the last 10 years (37)
| Jul 22, 2026 | Bofa Securities, Inc. reported in an SEC filing no longer being a 10% owner |
| Jul 22, 2026 | Bofa Securities, Inc. first listed as a 10% owner in an SEC filing |
| Jul 22, 2026 | Bank of America Na reported in an SEC filing no longer being a 10% owner |
| Jul 22, 2026 | Bank of America Na first listed as a 10% owner in an SEC filing |
| Jul 22, 2026 | Bank of America Corp /de/ reported in an SEC filing no longer being a 10% owner |
| Jul 22, 2026 | Bank of America Corp /de/ first listed as a 10% owner in an SEC filing |
| Jul 13, 2026 | Hrt Financial LP reported in an SEC filing no longer being a 10% owner |
| Jul 10, 2026 | Bofa Securities, Inc. reported in an SEC filing no longer being a 10% owner |
| Jul 10, 2026 | Bank of America Na reported in an SEC filing no longer being a 10% owner |
| Jul 10, 2026 | Bank of America Corp /de/ reported in an SEC filing no longer being a 10% owner |
| Jul 9, 2026 | Hrt Financial LP became a 10% owner |
| Jul 7, 2026 | Bofa Securities, Inc. became a 10% owner |
| Jul 7, 2026 | Bank of America Na became a 10% owner |
| Jul 7, 2026 | Bank of America Corp /de/ became a 10% owner |
| May 18, 2026 | Indranil Dey no longer listed as a 10% owner in SEC filings |
| Mar 29, 2024 | The company announced the departure of Frances P Scally as CFO in an SEC filing |
| Dec 14, 2023 | Indranil Dey first listed as a 10% owner in an SEC filing |
| Sep 26, 2023 | The company announced the departure of Kenneth R Fisher as Chief Financial Officer in an SEC filing |
| Sep 26, 2023 | Frances P Scally became CFO |
| Mar 7, 2023 | Jason Cook became Chief Technology Officer |
| Feb 13, 2023 | Svetlana Dey no longer listed as a 10% owner in SEC filings |
| Feb 13, 2023 | Indranil Dey no longer listed as a 10% owner in SEC filings |
| Feb 13, 2023 | Douglas Clark Wurth no longer listed as a 10% owner in SEC filings |
| Mar 23, 2022 | The company announced the departure of Gordon Winston Kinder as Chief Financial Officer in an SEC filing |
| Mar 23, 2022 | Kenneth R Fisher became Chief Financial Officer |
| Feb 28, 2022 | Indranil Dey listed as President and CEO (previously Chief Technology Officer) in SEC filings |
| Nov 13, 2021 | Gary G Gemignani became a director |
| Nov 9, 2021 | Svetlana Dey became a director |
| Nov 9, 2021 | Svetlana Dey became a 10% owner |
| Nov 9, 2021 | Indranil Dey became a director |
| Nov 9, 2021 | Indranil Dey became a 10% owner |
| Nov 9, 2021 | Indranil Dey became Chief Technology Officer |
| Nov 9, 2021 | Gordon Winston Kinder became Chief Financial Officer |
| Nov 9, 2021 | Fred S Zeidman became a director |
| Nov 9, 2021 | Douglas Clark Wurth became a director |
| Nov 9, 2021 | Douglas Clark Wurth became a 10% owner |
| Nov 9, 2021 | Donald R Chase became a director |
- Prev
- 1
Not reported recently (2)
- Gary G Gemignani · Last reported as a director in an SEC filing dated May 14, 2024
- Jason Cook · Last reported as Chief Technology Officer in an SEC filing dated Mar 16, 2023
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.